Use of serum copper/zinc ratio in patients with large bowel cancer

Gray, B.N., Walker, C. and Barnard, R. (1982) Use of serum copper/zinc ratio in patients with large bowel cancer. Journal of Surgical Oncology, 21 4: 230-232. doi:10.1002/jso.2930210407

Author Gray, B.N.
Walker, C.
Barnard, R.
Title Use of serum copper/zinc ratio in patients with large bowel cancer
Journal name Journal of Surgical Oncology   Check publisher's open access policy
ISSN 0022-4790
Publication date 1982
Sub-type Article (original research)
DOI 10.1002/jso.2930210407
Volume 21
Issue 4
Start page 230
End page 232
Total pages 3
Place of publication United States
Publisher John Wiley & Sons, Inc.
Language eng
Abstract The serum copper/zinc ratio was measured in 44 patients bearing primary large bowel malignancies. Measurements were repeated following removal of the primary tumour and again at the time of development of clinical evidence of cancer recurrence in order to evaluate the clinical value of the ratio to accurately reflect the presence or absence of malignancy. Estimation of serum copper levels do reflect the presence of malignancy, but the copper/zinc ratio is of no added value. As other acute phase proteins have been shown to be superior to serum copper as markers for monitoring of cancer patients, it is concluded that in patients with large bowel cancer, monitoring with serum copper/zinc is of no clinical value.
Keyword Colon cancer
Colon resection
Digestive system
Large intestine
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Journal Article
Sub-type: Article (original research)
Collection: School of Chemistry and Molecular Biosciences
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 14 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 11 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Wed, 16 Feb 2011, 16:10:10 EST by Professor Ross Barnard on behalf of School of Chemistry & Molecular Biosciences